NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 52 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $31,027,000 | -32.2% | 1,573,357 | 0.0% | 2.10% | -94.2% |
| Q1 2021 | $45,737,000 | -4.0% | 1,573,357 | 0.0% | 36.38% | -41.2% |
| Q4 2020 | $47,665,000 | +90.4% | 1,573,357 | 0.0% | 61.89% | +58.9% |
| Q3 2020 | $25,032,000 | -19.4% | 1,573,357 | 0.0% | 38.95% | +104.4% |
| Q2 2020 | $31,058,000 | +60.1% | 1,573,357 | 0.0% | 19.06% | +137.3% |
| Q1 2020 | $19,399,000 | -33.3% | 1,573,357 | 0.0% | 8.03% | +4.7% |
| Q4 2019 | $29,091,000 | +33.5% | 1,573,357 | 0.0% | 7.67% | +16.1% |
| Q3 2019 | $21,791,000 | -5.4% | 1,573,357 | 0.0% | 6.61% | -44.2% |
| Q2 2019 | $23,034,000 | – | 1,573,357 | – | 11.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |